TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.400nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.600nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.720nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.740nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.740nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.800nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.900nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.920nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.920nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.960nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.970nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.980nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 0.990nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.01nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.01nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.02nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.07nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.10nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.12nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.16nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.20nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.27nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.28nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.32nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.33nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.34nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.34nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.40nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.44nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.45nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.47nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.49nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.52nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.62nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.62nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.62nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.67nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.71nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.75nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.77nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.80nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.88nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.90nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.90nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.90nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase 5(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.90nMAssay Description:In this test, the fluorescence-resonance energy transfer (TR-FRET) method was used to determine the inhibition effect of the test compounds on ASK1 k...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.94nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Jiangsu Hansoh Pharmaceutical Group
US Patent
Jiangsu Hansoh Pharmaceutical Group
US Patent
Affinity DataIC50: 1.95nMAssay Description:In this experiment, the inhibitory effect of the compounds on FGFR4 kinase activity was tested by a fluorescence resonance energy transfer (TR-FRET) ...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)